Title of Collaborative Activity: |
Registry-based studies of hematologic malignancy incidence and survivorship |
Description of Collaborative Activity: |
NCI and FDA investigators are collaborating to utilize registry-based data to describe incidence trends of hematologic malignancies as well as second cancer risk and mortality patterns among hematologic malignancy survivors. |
Type of Collaborative Activity: |
Research Initiative
|
Year the Collaborative Activity Originated: |
2019 |
NIH Participating Institutes/Centers/Office of the Director: |
NCI |
HHS Agency Collaborators on this Activity: |
FDA |
